Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LP-261

🥰Excellent
Catalog No. T9595Cas No. 915412-67-8

LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine site on tubulin, inducing G2/M arrest.

LP-261

LP-261

🥰Excellent
Purity: 99.76%
Catalog No. T9595Cas No. 915412-67-8
LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine site on tubulin, inducing G2/M arrest.
Pack SizePriceAvailabilityQuantity
1 mg$32In Stock
2 mg$45In Stock
5 mg$72In Stock
10 mg$122In Stock
25 mg$197In Stock
50 mg$372In Stock
100 mg$556In Stock
1 mL x 10 mM (in DMSO)$79In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "LP-261"

Select Batch
Purity:99.76%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine site on tubulin, inducing G2/M arrest.
Targets&IC50
Tubulin polymerization:3.2 μM (EC50)
In vitro
LP-261 was tested as a single agent in colon adenocarcinoma (SW620) and prostate cancer (LNCaP and PC3) xenografts, evaluating several different dosing schedules. LP-261 was also used in combination with bevacizumab in the SW620 xenograft model. LP-261 also exhibited high oral bioavailability and apparent lack of efflux by intestinal transporters such as ABCB1. LP-261 is a very potent inhibitor of angiogenesis, preventing microvessel outgrowth in the rat aortic ring assay and HUVEC cell proliferation at nanomolar concentrations. Complete inhibition of tumor growth was achieved in the PC3 xenograft model and shown to be schedule dependent. Excellent inhibition of tumor growth in the SW620 model was observed, comparable with paclitaxel[1].
In vivo
LP-261 significantly inhibits growth of a human non-small-cell lung tumor (NCI-H522) in a mouse xenograft model[2].
Chemical Properties
Molecular Weight421.47
FormulaC22H19N3O4S
Cas No.915412-67-8
SmilesCOc1cc(ccn1)C(=O)c1cc(NS(C)(=O)=O)cc(c1)-c1cccc2[nH]ccc12
Relative Density.1.391 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 22 mg/ml (52.20 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3726 mL11.8632 mL23.7265 mL118.6324 mL
5 mM0.4745 mL2.3726 mL4.7453 mL23.7265 mL
10 mM0.2373 mL1.1863 mL2.3726 mL11.8632 mL
20 mM0.1186 mL0.5932 mL1.1863 mL5.9316 mL
50 mM0.0475 mL0.2373 mL0.4745 mL2.3726 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LP-261 | purchase LP-261 | LP-261 cost | order LP-261 | LP-261 chemical structure | LP-261 in vivo | LP-261 in vitro | LP-261 formula | LP-261 molecular weight